Life expectancy and years of life lost in chronic obstructive pulmonary disease: findings from the NHANES III Follow-up Study - Wikidata - wikimedia - TriplyDB

Life expectancy and years of life lost in chronic obstructive pulmonary disease: findings from the NHANES III Follow-up Study

Life expectancy and years of life lost in chronic obstructive pulmonary disease: findings from the NHANES III Follow-up Study

http://www.wikidata.org/entity/Q37168335

about

Tiotropium Bromide in Chronic Obstructive Pulmonary Disease and Bronchial Asthma Personalizing annual lung cancer screening for patients with chronic obstructive pulmonary disease: A decision analysis.Optimizing management of chronic obstructive pulmonary disease in the upcoming decade.Systematic review of the evidence relating FEV1 decline to giving up smoking Deaths from nonmalignant respiratory disease in styrene-exposed workers: does obliterative bronchiolitis contribute to mortality?Tiotropium HandiHaler(®) and Respimat(®) in COPD: a pooled safety analysis.Long-acting bronchodilator use after hospitalization for COPD: an observational study of health insurance claims data Differential expression of vitamin E and selenium-responsive genes by disease severity in chronic obstructive pulmonary disease Co-morbidities are the key nominators of the health related quality of life in mild and moderate COPD.Advanced therapies for COPD-What's on the horizon? Progress in lung volume reduction and lung transplantation Smoking cessation can improve quality of life among COPD patients: validation of the clinical COPD questionnaire into Greek Predicted postoperative lung function is associated with all-cause long-term mortality after major lung resection for cancer.Characteristics and survival of head and neck cancer by HPV status: a cancer registry-based study.Application of the new GOLD COPD staging system to a US primary care cohort, with comparison to physician and patient impressions of severity.Cost Effectiveness of Free Access to Smoking Cessation Treatment in France Considering the Economic Burden of Smoking-Related Diseases.Carotid endarterectomy in asymptomatic patients with limited life expectancy.Effect of Radix Stemonae concentrated decoction on the lung tissue pathology and inflammatory mediators in COPD rats Contribution of the environment and comorbidities to chronic obstructive pulmonary disease phenotypes.Adherence to GOLD guideline treatment recommendations among pulmonologists in Turkey Early and Long-term Outcomes of Older Adults after Acute Care Encounters for Chronic Obstructive Pulmonary Disease Exacerbation Identification of factors involved in medication compliance: incorrect inhaler technique of asthma treatment leads to poor compliance.The Tiotropium Safety and Performance in Respimat Trial (TIOSPIR), a large scale, randomized, controlled, parallel-group trial-design and rationale Inflammatory biomarkers predicting prognosis in patients with acute dyspnea Microsimulation model predicts survival benefit of radiofrequency ablation and stereotactic body radiotherapy versus radiotherapy for treating inoperable stage I non-small cell lung cancer.Diagnosis of chronic obstructive pulmonary disease in the primary care setting The disease burden of chronic obstructive pulmonary disease in Greece.Body mass index, airflow obstruction and dyspnea and body mass index, airflow obstruction, dyspnea scores, age and pack years-predictive properties of new multidimensional prognostic indices of chronic obstructive pulmonary disease in primary care.Risk assessment of readmissions following an initial COPD-related hospitalization.Cost-effectiveness analysis of umeclidinium/vilanterol for the management of patients with moderate to very severe COPD using an economic model.Impact of inhalation therapy on oral health.The management of asthma and chronic obstructive pulmonary disease: current status and future perspectives.Cross-Sectional Study of Chronic Obstructive Pulmonary Disease Prevalence Among Smokers, Ex-Smokers, and Never-Smokers in Almaty, Kazakhstan: Study Protocol.Stratification of telehealthcare for patients with chronic obstructive pulmonary disease using a predictive algorithm as decision support: A pilot study.Chronic respiratory diseases and quality of life in elderly nursing home residents.Economic evaluation of a hospital-initiated intervention for smokers with chronic disease, in Ontario, Canada Improving hip fractures outcomes for COPD patients.Roy's adaptation model-guided education for adaptation to chronic obstructive pulmonary disease.Survival and mortality following TBI.Inhaled therapies in patients with moderate COPD in clinical practice: current thinking.Role of BMI, airflow obstruction, St George's Respiratory Questionnaire and age index in prognostication of Asian COPD.

P2860

Q26780553-0C4B3128-3770-41DF-9357-8466D03964F7 Q27336183-78709DA5-DA58-4BF0-BE95-D12C301746DE Q27693341-C3B6448C-9F86-4DD6-8FF9-EADB41C88001 Q28385603-6A4FAD68-0458-47DC-81FC-A57F75F9CB54 Q29417854-BCD8EE49-6AF6-4A6B-935F-701A58FF3D7B Q30620671-D78BE487-1638-489F-A11C-35781E963DE5 Q30822043-877C83C4-27B9-4F7C-AE14-CB7926A7AFD4 Q33766550-E5F66ABB-2AD6-4F41-A5E1-2FC4703F228E Q34500895-67B45770-D18A-4954-9FA6-9B05C7563AEE Q34628616-4595F908-18B7-4CE7-AA30-9775CADB4296 Q34633721-CB949E9F-DDB6-4731-AF69-277B000A648E Q35558808-A28D3C22-FE91-4DB5-AAA6-C649EF04EE26 Q35870672-3FF40DD4-3B8D-4673-B337-8A25BD86DC45 Q35915157-3542E149-A06E-4E30-B27F-A16D55F5DEF1 Q35933786-3885A929-A506-496D-AFD4-59A074930DFE Q36060454-D73F7073-31A7-4CD4-8EEB-8490D21B905B Q36189249-CAF711AD-4385-4CF5-8FF5-E8A849B004E9 Q36237935-C6A696C4-CF51-40C4-97E7-1BD97FB18F0B Q36390663-E5574F0D-5D65-46DE-B46B-00957FC285F5 Q36490109-5750B825-88EA-4A21-8FFA-D96179F8994E Q36581576-FA616A69-F19C-4AA4-8F53-24B895822913 Q36752114-465B201A-DD14-44A6-8DBD-53EC875F7F68 Q36761565-26AA9E15-22A0-412D-B3D3-1AC0C3081478 Q37044288-1E45AB26-D25D-48FB-B095-0022712E04EA Q37082651-E6C63234-E0B4-4043-9FE0-009422AA4580 Q37259433-50F77781-F08A-49F5-BF93-42164F404349 Q37350573-26F6DFD2-B9FE-45C2-920D-4C7CB5903FC0 Q37359282-00FC5093-FED8-4970-8763-56596E6E1822 Q37730578-879C16B7-9414-4116-AAC1-0BBAC914DC12 Q37956301-A2ACB512-36C7-4075-BC1E-51083C607AE8 Q37979254-0D930FA7-C39C-42A2-BCD0-2F25FF525A99 Q38372859-0D41007F-B67B-49AD-902B-F6173A7B10F6 Q38880640-D553AFF7-CA13-4572-9353-A1DE19A3CDE8 Q40860561-BA9C40D7-E323-4430-9992-59AA27C8EDBA Q41877868-2D65779B-8BC6-4E9F-8E7B-34FC5D252707 Q46226194-C0A71518-F2BD-43B0-B18A-C537A4F15189 Q46279982-48B69905-DC1E-41A9-B6E9-724FE2A8773C Q47376134-0C188F7D-4EF0-4E84-AC11-0F5E288AA8FD Q47661714-4AFC7AFF-1345-4CC5-82F8-8E8C26DC9964 Q47665614-29F945E2-FD68-4CB9-B62F-CA0E7E613004

P2860

Life expectancy and years of life lost in chronic obstructive pulmonary disease: findings from the NHANES III Follow-up Study

http://www.wikidata.org/entity/Q37168335

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 15 April 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Life expectancy and years of l ...... the NHANES III Follow-up Study

@en

Life expectancy and years of l ...... he NHANES III Follow-up Study.

@nl

type

label

Life expectancy and years of l ...... the NHANES III Follow-up Study

@en

Life expectancy and years of l ...... he NHANES III Follow-up Study.

@nl

prefLabel

Life expectancy and years of l ...... the NHANES III Follow-up Study

@en

Life expectancy and years of l ...... he NHANES III Follow-up Study.

@nl

P1433

Q37168335-F2ACDD00-B6FD-4757-BCA2-BC3D82422351

P1476

Q37168335-4EDF8899-0A2D-405B-A421-67593F4B9B0A

P2093

Q37168335-00A6F4D8-3C5D-40F3-A6FD-341F3D74F293

Q37168335-3242390B-D14E-4700-82AC-42E5B472E009

Q37168335-9D638A0D-7205-407F-B71B-AB16B0416C11

Q37168335-F521BC87-FDC8-4C4B-8340-9461F0B9CF7A

P2860

Q37168335-234DFC3D-1562-41F5-9333-1E70C918B232

Q37168335-375ED532-7292-4F31-A1FD-EA6C73420968

Q37168335-53E32956-DEE4-4158-8E57-63BC5903AC68

Q37168335-55A6334F-BA3F-4D2E-B53A-A1AFBEB6A1B5

Q37168335-5EF1DA0B-4FFB-4BBF-921D-A7EB8D4BB9BD

Q37168335-77D3BC40-2811-4A71-A6E8-791BBDBAA371

Q37168335-7A64717F-9AEC-45EC-AC5A-0E7FCB1DF2B9

Q37168335-80189233-EA2C-4815-B7C5-91B3784B4827

Q37168335-84780F7B-2FC3-450C-B827-71F337FCA56A

Q37168335-9335EDE1-CD85-442B-AC61-6C046C153C01

P304

Q37168335-887FECA3-6F1D-4CC4-B003-1F0E0940C7CB

P31

Q37168335-2FFF3DBC-F78C-41BF-8061-C8CC4643527D

P356

Q37168335-C901F0F2-1CF3-4288-B7BB-078F1D290BD7

P407

Q37168335-82E9E5AD-A6FA-44AB-9020-1D245BE5B3EE

P478

Q37168335-283C1470-6964-44B7-8691-EC6DB432DFFD

P50

Q37168335-3353A42A-10C4-43E5-BA0D-D3DE97994380

P577

Q37168335-36979964-A656-4C1B-B31D-C993B593DF1B

P698

Q37168335-EE5672BE-44B0-4CD0-9FD4-F90701384209

P921

Q37168335-2F864C36-5094-4ED4-8179-26CF58F19C1C

Q37168335-8F35C1C2-FE07-4618-BFA6-9F18D14FEDD8

P932

Q37168335-3EA2CEE2-37AE-429D-B3CB-288160AA06E1

P356

P1433

International Journal of Chronic Obstructive Pulmonary Disease

P1476

Life expectancy and years of l ...... the NHANES III Follow-up Study

@en

P2093

David J Strauss

http://www.w3.org/2001/XMLSchema#string

David M Mannino

http://www.w3.org/2001/XMLSchema#string

Robert M Shavelle

http://www.w3.org/2001/XMLSchema#string

Scott J Kush

http://www.w3.org/2001/XMLSchema#string

P2860

Spirometric reference values from a sample of the general U.S. population

Mortality in relation to smoking: 50 years' observations on male British doctors

Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis.

Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994.

Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study

The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.

Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study.

Epidemiology and costs of chronic obstructive pulmonary disease.

Pulmonary function, smoking cessation and 30 year mortality in middle aged Finnish men.

Estimation of future mortality rates and life expectancy in chronic medical conditions.

P304

137-148

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/COPD.S5237

http://www.w3.org/2001/XMLSchema#string

P407

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-04-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19436692

http://www.w3.org/2001/XMLSchema#string

P921

life expectancy

chronic obstructive pulmonary disease

P932

2672796

http://www.w3.org/2001/XMLSchema#string